These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7739846)

  • 21. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.
    Nakamura R; Yamamoto N; Shiina N; Miyaki T; Ikebe D; Itami M; Shida T; Miyazaki M
    Breast; 2016 Apr; 26():141-7. PubMed ID: 26732051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas.
    Skoog L; Humla S; Isaksson S; Tani E
    Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH; Buchmann J
    Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on the relationship among estrogen receptor, progesterone receptor and glucose-6-phosphate dehydrogenase activity in primary breast cancer].
    Zeng QF; Xu JH
    Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):107-9. PubMed ID: 1914015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group.
    Fernö M; Stål O; Baldetorp B; Hatschek T; Källström AC; Malmström P; Nordenskjöld B; Rydën S
    Breast Cancer Res Treat; 2000 Jan; 59(1):69-76. PubMed ID: 10752681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.
    Chebil G; Bendahl PO; Fernö M; ;
    Acta Oncol; 2003; 42(1):43-7. PubMed ID: 12665330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assay.
    Gritzapis AD; Baxevanis CN; Missitzis I; Katsanou ES; Alexis MN; Yotis J; Papamichail M
    Breast Cancer Res Treat; 2003 Jul; 80(1):1-13. PubMed ID: 12889594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The estrogen receptor/progesterone receptor quotient as an index of the transcriptional activity of estrogen receptors in breast cancer].
    Navarro MA; Díez Gibert O; Fernández-Montolí ME; Rosel P; Bonnin MR
    Med Clin (Barc); 1995 May; 104(18):681-2. PubMed ID: 7769876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor, progesterone receptor, and HER-2/neu protein in breast cancers from pregnant patients.
    Elledge RM; Ciocca DR; Langone G; McGuire WL
    Cancer; 1993 Apr; 71(8):2499-506. PubMed ID: 8095853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
    Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dna synthesis and expression of steroid receptors in cells of human breast carcinoma].
    Simone G; Mangia A; Petroni S; Marzullo F; Paradiso A; Schittulli F
    Pathologica; 1996 Apr; 88(2):111-6. PubMed ID: 8927445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Receptor (ER, PgR) levels as prognostic factors in the endocrine therapy of pre- and post-menopausal patients with stage III infiltrative ductal and lobular cancer of the breast].
    Calzada L; Salazar EL; Pedron Nuevo N
    Ginecol Obstet Mex; 1996 Mar; 64():135-9. PubMed ID: 8729191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunocytochemical localization of estrogen and progesterone receptors in human thyroid.
    Money SR; Muss W; Thelmo WL; Boeckl O; Pimpl W; Kaindl H; Sungler P; Kirwin J; Waclawicek H; Jaffe BM
    Surgery; 1989 Dec; 106(6):975-8; discussion 979. PubMed ID: 2686061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
    Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
    Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.